Extracellular Adenosine: A Safety Signal That Dampens Hypoxia-Induced Inflammation During Ischemia
- 15 October 2011
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 15 (8), 2221-2234
- https://doi.org/10.1089/ars.2010.3665
Abstract
Traditionally, the single most unique feature of the immune system has been attributed to its capability to discriminate between self (e.g., host proteins) and nonself (e.g., pathogens). More recently, an emerging immunologic concept involves the notion that the immune system responds via a complex system for sensing signals of danger, such as pathogens or host-derived signals of cellular distress (e.g., ischemia), while remaining unresponsive to nondangerous motifs. Experimental studies have provided strong evidence that the production and signaling effects of extracellular adenosine are dramatically enhanced during conditions of limited oxygen availability as occurs during ischemia. As such, adenosine would fit the bill of signaling molecules that are enhanced during situations of cellular distress. In contrast to a danger signal, we propose here that extracellular adenosine operates as a countermeasure, in fact as a safety signal, to both restrain potentially harmful immune responses and to maintain and promote general tissue integrity during conditions of limited oxygen availability. Antioxid. Redox Signal. 15, 2221–2234.Keywords
This publication has 125 references indexed in Scilit:
- The InflammasomesCell, 2010
- Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearanceNature, 2009
- A2B adenosine receptors in immunity and inflammationTrends in Immunology, 2009
- Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia–reperfusion injuryKidney International, 2009
- Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantationProceedings of the National Academy of Sciences of the United States of America, 2009
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent StrokeThe New England Journal of Medicine, 2008
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- Neutrophils as Sources of Extracellular Nucleotides: Functional Consequences at the Vascular InterfaceTrends in Cardiovascular Medicine, 2008
- The A2b adenosine receptor protects against vascular injuryProceedings of the National Academy of Sciences of the United States of America, 2008
- Physiological roles for ecto-5’-nucleotidase (CD73)Purinergic Signalling, 2006